Found: 13
Select item for more details and to access through your institution.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 497, doi. 10.1007/s10549-023-07159-9
- By:
- Publication type:
- Article
Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183679
- By:
- Publication type:
- Article
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y
- By:
- Publication type:
- Article
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y
- By:
- Publication type:
- Article
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 953, doi. 10.3390/jcm12030953
- By:
- Publication type:
- Article
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5467, doi. 10.3390/cancers14215467
- By:
- Publication type:
- Article
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2824, doi. 10.3390/cancers13112824
- By:
- Publication type:
- Article
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine Tumors.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2771, doi. 10.3390/cancers13112771
- By:
- Publication type:
- Article
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 99, doi. 10.3390/cancers12010099
- By:
- Publication type:
- Article
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2‐positive breast cancer.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 7, p. 1, doi. 10.1111/eci.13535
- By:
- Publication type:
- Article
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immunotherapy in breast cancer: an overview of current strategies and perspectives.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00508-3
- By:
- Publication type:
- Article